ARCHIVES

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

This article is from The Cancer Letter archive.

Vol. 19 No. 43 | November 5, 1993

Download PDF Visit The Full Archive

Related Articles

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978

Cancer Survivors Day Planned or June 5

April 22, 1988

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

NCI May Seek Cuts In R01s, P01s If Congress Approves Rescission

January 30, 1981

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006